Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment

Open Access
Authors
  • R.P. Kloppenborg
  • E. Richard
  • M.E.S. Sprengers
  • D. Troost
Publication date 2010
Journal Journal of neuroinflammation
Volume | Issue number 7 | 1
Pages (from-to) 18
Organisations
  • Faculty of Medicine (AMC-UvA)
Abstract
ABSTRACT: Cerebral amyloid angiopathy (CAA) is a common but often asymptomatic disease, characterized by deposition of amyloid in cerebral blood vessels. We describe successful treatment of CAA encephalopathy with dexamethasone in a patient with CAA-related inflammation causing subacute progressive encephalopathy and seizures, which is an increasingly recognized subtype of CAA. The two pathological subtypes of CAA-related inflammation are described and a review of the literature is performed concerning immunosuppressive treatment of CAA-related inflammation with special attention to its pathological subtypes. Immunosuppressive therapy appears to be an appropriate treatment for CAA encephalopathy
Document type Article
Published at https://doi.org/10.1186/1742-2094-7-18
Downloads
340463.pdf (Final published version)
Permalink to this page
Back